Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

Affiliations

• ¹ Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
• ² Department of Breast Oncology, Academy of Military Medical Sciences, Beijing 100089, China.
• ³ Department of Breast Surgery, Liaocheng People's Hospital, Liaocheng 252000, China.
• ⁴ Department of Medical Oncology, The First Affiliated Hospital of Xinxiang University, Xinxiang 453100, China.
• ⁵ Department of Breast Surgery, Hongqing Cancer Hospital, Chongqing 400030, China.
• ⁶ Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
• ⁷ Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China.
• ⁸ Department of Breast Surgery, Sichuan Province People's Hospital, Chengdu 610072, China.
• ⁹ Department of Medical Oncology, Zhongshan University Cancer Center, Guangzhou 510060, China.
• ¹⁰ Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
• ¹¹ Department of Breast Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
• ¹² Department of Research and Development, Jiangsu Hengrui Medicine Co., Ltd., Shanghai 200120, China.